FDA
approval
· 2019-05-28
FDA Approved: RANOLAZINE — Original Application (Sun Pharmaceutical Industries, Inc.)
Summary
FDA approved Sun Pharmaceutical Industries' generic ranolazine under an original application, expanding access to this antianginal therapy for chronic angina.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for RANOLAZINE (RANOLAZINE)